FDA inspection
Immunexpress, Inc: FDA inspection ending Dec 6, 2024
FDA inspection 1255908 · Voluntary Action Indicated (VAI) · Seattle, WA
Key facts
| Inspection ID | 1255908 |
|---|---|
| Firm | Immunexpress, Inc |
| FEI number | 3016504919 |
| Address | 425 Pontius Ave N Ste 470 |
| City | Seattle |
| State | WA |
| ZIP | 98109 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Dec 6, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data